Enavate Sciences’s Braveheart Bio BRVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$74.2M Buy
+3,674,656
New +$96.8M 26.53% 3

Other funds holding BRVE

Enavate Sciences's BRVE Position: Q3 2026 in Review

Enavate Sciences opened a new position in Braveheart Bio (BRVE) in Q3 2026: 3,674,656 shares worth $74.2M. The stake represents 26.53% of the portfolio and ranks #3 among its holdings.

64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.

  • Enavate Sciences held 3,674,656 shares of Braveheart Bio worth $74.2M as of Q3 2026.
  • Braveheart Bio was a new Enavate Sciences position in Q3 2026.
  • Braveheart Bio made up 26.53% of Enavate Sciences's portfolio in Q3 2026, its #3 holding.
  • 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.

Based on Enavate Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.